The one and only one patent owner of four patents for IgY(ΔFc) antibody's manufacture & applications in the world. This commercialized technology is solely owned by Good Biotech Corp. and is also patented-protected worldwide including all the major and dominant markets. The patents have been granted by many countries such as United States, Japan, European Union, Russia, Australia, China, Taiwan, New Zealand, Singapore, Korea, Malaysia, Mexico, Hong Kong, Israel etc.
